IRMD
IRADIMED CORPCompany Information
- Company Name
- IRADIMED CORP
- CIK
- CIK0001325618
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- IRMD: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- IRMD
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-03
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 186,481
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 7,332,987
- Shares outstanding
- 12,784,000
- Ownership
- 57.36%
Earnings Market Reaction
- Filing date
- 2026-07-31
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 59 | 56 | 51 | 57 | 53 | 50 | 52 | 52 | 49 | 45 | 50 | 47 | ||||||
| Accounts Receivable Net Current | 13 | 13 | 14 | 14 | 11 | 13 | 11 | 10 | 12 | 13 | 12 | 13 | ||||||
| Inventory Net | 12 | 12 | 12 | 12 | 11 | 11 | 10 | 11 | 12 | 13 | 13 | 12 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 5 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Taxes | 1 | 3 | - | 2 | 0 | - | - | - | - | - | - | - | ||||||
| Assets Current | 87 | 86 | 81 | 85 | 77 | 75 | 75 | 74 | 74 | 72 | 76 | 72 | ||||||
| Property Plant And Equipment Net | 24 | 24 | 24 | 24 | 23 | 20 | 17 | 14 | 10 | 9 | 9 | 9 | ||||||
| Finite Lived Intangible Assets Net | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | 0 | 0 | 0 | 0 | 2 | 2 | 2 | ||||||
| Deferred Income Tax Assets Net | 0 | 0 | 0 | 2 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 115 | 114 | 109 | 115 | 106 | 102 | 98 | 94 | 90 | 88 | 92 | 87 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 2 | 3 | ||||||
| Employee Related Liabilities Current | 3 | 2 | 3 | 4 | 3 | 2 | 4 | 3 | 3 | 2 | 3 | 2 | ||||||
| Accrual For Taxes Other Than Income Taxes Current | 1 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Product Warranty Accrual Classified Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Contract With Customer Liability Current | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 3 | 2 | ||||||
| Dividends Payable Current | - | - | - | - | - | - | - | - | - | - | 8 | - | ||||||
| Operating Lease Liability Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Current | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Income Taxes Current | 0 | 4 | 2 | 3 | - | 1 | - | - | - | 1 | 0 | - | ||||||
| Liabilities Current | 9 | 12 | 10 | 13 | 9 | 8 | 9 | 8 | 7 | 8 | 16 | 8 | ||||||
| Contract With Customer Liability Noncurrent | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 2 | 2 | 2 | ||||||
| Liabilities | 13 | 16 | 14 | 16 | 12 | 12 | 12 | 11 | 10 | 12 | 21 | 13 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 32 | 31 | 30 | 32 | 31 | 31 | 30 | 30 | 29 | 29 | 28 | 28 | ||||||
| Retained Earnings Accumulated Deficit | 70 | 67 | 64 | 66 | 63 | 59 | 57 | 54 | 50 | 47 | 43 | 47 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Stockholders Equity | 102 | 99 | 95 | 98 | 94 | 90 | 87 | 83 | 80 | 76 | 71 | 75 | ||||||
| Liabilities And Stockholders Equity | 115 | 114 | 109 | 115 | 106 | 102 | 98 | 94 | 90 | 88 | 92 | 87 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | ||||||
| Common Stock Shares Issued | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | ||||||
| Shares Outstanding | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIRADIMED CORP (IRMD) — SEC Financial Statements & Analysis
IRADIMED CORP (IRMD) is a surgical & medical instruments & apparatus company, incorporated in DE. IRADIMED CORP trades on Nasdaq as: IRMD. IRADIMED CORP (IRMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-31. Based on that filing, IRADIMED CORP carries a market cap of $1.22B, a P/E ratio of 52.87x, a P/B ratio of 11.98x, a P/S ratio of 14.12x, an enterprise value of $1.16B, and an EV/EBITDA multiple of 39.74x. On profitability, it posts a gross margin of 75.86%, an operating margin of 31.91%, a net margin of 26.70%, a Return on Equity (ROE) of 23.52%, a Return on Assets (ROA) of 20.82%, and a Return on Invested Capital (ROIC) of 48.95%. Per share, it reports EPS of $1.80, diluted EPS of $1.79, free cash flow per share of $1.96, and a dividend per share of $1.24. Over the trailing year, it posted revenue growth of 11.21% year-over-year, net income growth of 11.61% year-over-year, and EPS growth of 11.01% year-over-year. On the balance sheet, it maintains a current ratio of 9.46x, a quick ratio of 7.97x, working capital of $77.56M, a debt-to-equity ratio of 0.13x, a debt ratio of 0.12, free cash flow of $25.12M (TTM), and net debt of $-59.08M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.22B
- P/E TTM
- 52.87x
- EPS TTM
- $1.80
- P/B TTM
- 11.98x
- ROE TTM
- 23.52%
- ROA TTM
- 20.82%
- Debt To Equity
- 0.13x
- Free Cash Flow TTM
- $25.12M
- Net Revenue TTM Growth 1Y
- 11.21%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is IRADIMED CORP in?
IRADIMED CORP (IRMD) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does IRMD trade on?
IRADIMED CORP (IRMD) trades on the Nasdaq.
Where is IRADIMED CORP incorporated?
IRADIMED CORP is incorporated in DE.
When was IRADIMED CORP (IRMD)'s most recent SEC filing?
IRADIMED CORP (IRMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-31.
What is IRMD's market cap?
IRADIMED CORP (IRMD) has a market capitalization of $1.22B as of 2026-06-30.
What is IRMD's P/E ratio?
IRADIMED CORP (IRMD)'s trailing twelve month P/E ratio is 52.87x as of 2026-06-30.
What is IRMD's EPS (earnings per share)?
IRADIMED CORP (IRMD)'s trailing twelve month EPS is $1.80 as of 2026-06-30.
What is IRMD's ROE (return on equity)?
IRADIMED CORP (IRMD)'s trailing twelve month Return on Equity (ROE) is 23.52% as of 2026-06-30.
What is IRMD's ROA (return on assets)?
IRADIMED CORP (IRMD)'s trailing twelve month Return on Assets (ROA) is 20.82% as of 2026-06-30.
What is IRMD's ROIC (return on invested capital)?
IRADIMED CORP (IRMD)'s trailing twelve month Return on Invested Capital (ROIC) is 48.95% as of 2026-06-30.
What is IRMD's EV/EBITDA?
IRADIMED CORP (IRMD)'s trailing twelve month EV/EBITDA is 39.74x as of 2026-06-30.